Skip to content

Effectiveness of Dry Needling in rigidity and gait in patients with Parkinson's Disease.

Effectiveness of Dry Needling in rigidity and gait in patients with Parkinson's Disease.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624001070527
Acronym
DNPD
Enrollment
32
Registered
2024-09-04
Start date
2025-05-02
Completion date
2025-06-06
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Given the high prevalence of rigidity in Parkinson Disease and its influence in the gait of these patients, our study aims to give a non-pharmacological solution, through Physiotherapy to this problem. In particular, an intervention of Dry Puncture (PS) in four muscles (Recto Femoral , biceps femoral, Medial Gastrocnemius and tibialis anterior), comparing the results with the obtained with the intervention of PS placebo in terms of perceived pain (algometry), walking functionality (time, speed and number of steps) and improvement of patterns electromyography and myotronometry ,in a population of patients with PD.

Interventions

The intervention consists of Dry Needling (DN) using disposable stainless steel needles of 0.3 mm × 50 mm or 0.3 mm x 40 mm (Agupunt, Barcelona, Spain), depending on the depth of the muscle to be treated (50 mm if the muscle is deep, 40mm if the muscle is superficial), and applied by a physiotherapist. The technique of DN consists on the fast entry and exit of the needle in the Myofascial Trigger Point of the Rectus Femoris, Gastrocnemius Medialis muscle, Tibialis Anterior and Biceps Femoris,

The intervention consists of Dry Needling (DN) using disposable stainless steel needles of 0.3 mm × 50 mm or 0.3 mm x 40 mm (Agupunt, Barcelona, Spain), depending on the depth of the muscle to be treated (50 mm if the muscle is deep, 40mm if the muscle is superficial), and applied by a physiotherapist. The technique of DN consists on the fast entry and exit of the needle in the Myofascial Trigger Point of the Rectus Femoris, Gastrocnemius Medialis muscle, Tibialis Anterior and Biceps Femoris, according to published application (1), until a minimum of 3-4 local twitch responses, always taking into account the tolerance of the patient, who will request to stop to the physiotherapist in any part of the process. The duration of each session is no more than 15 minutes. The intervention will be performed in the lower limb most affected by rigidity (which presents a rigidity measured by myotonometry and scored by Unified Parkinson’s Disease Rating Scale (UPDRS), in the target muscles). A puncture will be made in each muscle per session, 1 session per week, for 3 weeks. Each intervention will be recoded in an "intervention notebook" in order to monitor adherence. The intervention will be performed in the Parkinson´s Association of Seville, which it is an authorized health centre. The duration of each dry needling session will be approximately 45-60 seconds for muscle, until the local twitch responses disappeared or until the patient could no longer bear the pain. (1)Espejo-Antúnez L, Tejeda JFH, Albornoz-Cabello M, Rodríguez-Mansilla J, de la Cruz-Torres B, Ribeiro F, et al. Dry needling in the management of myofascial trigger points: A systematic review of randomized controlled trials. Vol. 33, Complementary Therapies in Medicine Churchill Livingstone; 2017. p. 46–57.

Sponsors

University of Seville
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with a diagnosis of Parkinson's Disease. Patients with 18 years-old and older. Patients who can walk (with or without support), with a score minor than 4 at Hoenh and Yarh scale. Patients who have signed the informed consent, show voluntariness to participate and can complete the scales and the protocol.

Exclusion criteria

Patients with comorbidity which affects their gait. Patients with needles fear. Patients unable to adequately meet the requirements of the study for any reason, condition or cause, at the discretion of the researcher. Patients with previous experiencia with dry-needling. Patients who have had infiltrations with botulinum toxin in the lower limb in the last 3 months. Patients who had participated in other Physical Therapy study in the last 6 months. Patient with another neurological diagnosis.

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 23, 2026